Search results

Found 150 pages
AUTHOR: PharmaTimes Reporter

Results per page

10 20 50 100

Sort by

Relevance Date

12 Aug 2013:

Allergan loses Indian IP for glaucoma drugs

Allergan has become the latest Western drugmaker to fall foul of India's intellectual property regime, losing patents on two of its glaucoma products. - News - PharmaTimes

by PharmaTimes Reporter

https://www.pharmatimes.com/news/allergan_loses_indian_ip_for_glaucoma_drugs_1005527

5 Jun 2013:

STI rates reach half a million in England

A new report shows that rates of sexually transmitted diseases reached nearly 500,000 last year as the UK government urges younger people to have safer sex. - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/sti_rates_reach_half_a_million_in_england_1005143

28 Aug 2013:

Vical slashes staff in wake of vaccine setback

Vical has eliminated almost 40% of its total workforce to conserve cash after the failure of its Allovectin immunotherapy for advanced melanoma. - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/vical_slashes_staff_in_wake_of_vaccine_setback_1005605

21 Mar 2013:

Almirall may pull Sativex in Germany

Spanish drugmaker Almirall has said it may decide to withdraw multiple sclerosis spasticity treatment Sativex from the German market after a breakdown in talks with the country's reimbursement authorities. - News - PharmaTimes

by PharmaTimes Reporter

https://www.pharmatimes.com/news/almirall_may_pull_sativex_in_germany_1004676

16 Dec 2013:

Double OK for Gilead's HIV triple therapy

Gilead and Johnson & Johnson scored a double late last week after their triple HIV therapy Complera/Eviplera was approved for wider use on both sides of the Atlantic. - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/double_ok_for_gileads_hiv_triple_therapy_1006187

14 Aug 2013:

Amgen cross-licensing deal with Servier goes through

Amgen has finalised a collaboration with Servier that will bolster the pipelines of both companies. - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/amgen_cross-licensing_deal_with_servier_goes_through_1005541

26 Aug 2013:

Icon offers risk-based monitoring service for trials

Irish contract research organisation (CRO) Icon has launched a new clinical trial monitoring service that promises to save sponsors time and money. - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/icon_offers_risk-based_monitoring_service_for_trials_1005590

30 Oct 2013:

Levin out as Teva seeks new CEO

Jeremy Levin has resigned as Teva's chief executive after a difference of opinion with the company's board on how to implement the company's new strategy. - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/levin_out_as_teva_seeks_new_ceo_1005929

6 Jun 2013:

'Big data' initiative unveiled for health research

An international initiative to promote the sharing of standardised genetic and clinical data was revealed yesterday by the Wellcome Trust Sanger Institute. - News - PharmaTimes

by PharmaTimes Reporter

https://www.pharmatimes.com/news/big_data_initiative_unveiled_for_health_research_1005147

29 Aug 2013:

PPD snaps up Acurian in patient recruitment push

Consolidation in the contract research sector continues apace, with Pharmaceutical Product Development (PPD) the latest to step up with a deal to buy patient recruitment specialist Acurian. - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/ppd_snaps_up_acurian_in_patient_recruitment_push_1005611